Page last updated: 2024-08-23

atomoxetine hydrochloride and Disease Exacerbation

atomoxetine hydrochloride has been researched along with Disease Exacerbation in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adams, WK; Kaur, S; Lam, FC; Muthukrishna, M; Riparip, LK; Rosi, S; Vonder Haar, C; Winstanley, CA	1
Dittmann, RW; Helsberg, K; Lehmann, M; Lehmkuhl, G; Schacht, A; Schneider-Fresenius, C; Wehmeier, PM	1
Goodman, DW	1
Kahn, DA; Markx, S	1

Reviews

1 review(s) available for atomoxetine hydrochloride and Disease Exacerbation

Article	Year
The consequences of attention-deficit/hyperactivity disorder in adults. Journal of psychiatric practice, 2007, Volume: 13, Issue:5 Topics: Achievement; Adult; Age Factors; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Disease Progression; Female; Health Care Costs; Humans; Impulsive Behavior; Male; Mental Disorders; Methylphenidate; Propylamines; Quality of Life; Sex Distribution; Social Adjustment; Substance-Related Disorders	2007

Article

Year

The consequences of attention-deficit/hyperactivity disorder in adults.

Journal of psychiatric practice, 2007, Volume: 13, Issue:5

Topics: Achievement; Adult; Age Factors; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Disease Progression; Female; Health Care Costs; Humans; Impulsive Behavior; Male; Mental Disorders; Methylphenidate; Propylamines; Quality of Life; Sex Distribution; Social Adjustment; Substance-Related Disorders

2007

Trials

1 trial(s) available for atomoxetine hydrochloride and Disease Exacerbation

Article	Year
Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany. Journal of child and adolescent psychopharmacology, 2011, Volume: 21, Issue:2 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Conduct Disorder; Disease Progression; Double-Blind Method; Female; Germany; Humans; Male; Placebos; Propylamines; Treatment Outcome	2011

Article

Year

Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.

Journal of child and adolescent psychopharmacology, 2011, Volume: 21, Issue:2

Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Conduct Disorder; Disease Progression; Double-Blind Method; Female; Germany; Humans; Male; Placebos; Propylamines; Treatment Outcome

2011

Other Studies

2 other study(ies) available for atomoxetine hydrochloride and Disease Exacerbation

Article	Year
Frontal Traumatic Brain Injury in Rats Causes Long-Lasting Impairments in Impulse Control That Are Differentially Sensitive to Pharmacotherapeutics and Associated with Chronic Neuroinflammation. ACS chemical neuroscience, 2016, 11-16, Volume: 7, Issue:11 Topics: Acute Disease; Adrenergic Uptake Inhibitors; Amantadine; Amphetamine; Animals; Atomoxetine Hydrochloride; Brain Injuries, Traumatic; Central Nervous System Stimulants; Chronic Disease; Disease Models, Animal; Disease Progression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agents; Frontal Lobe; Male; Motor Activity; Neuroimmunomodulation; Rats, Long-Evans; Severity of Illness Index	2016
An 18-year-old woman with new-onset suicidal ideation while being treated with atomoxetine. Journal of psychiatric practice, 2008, Volume: 14, Issue:1 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Disease Progression; Female; Humans; Propylamines; Self-Injurious Behavior; Suicide, Attempted	2008

Article

Year

Frontal Traumatic Brain Injury in Rats Causes Long-Lasting Impairments in Impulse Control That Are Differentially Sensitive to Pharmacotherapeutics and Associated with Chronic Neuroinflammation.

ACS chemical neuroscience, 2016, 11-16, Volume: 7, Issue:11

Topics: Acute Disease; Adrenergic Uptake Inhibitors; Amantadine; Amphetamine; Animals; Atomoxetine Hydrochloride; Brain Injuries, Traumatic; Central Nervous System Stimulants; Chronic Disease; Disease Models, Animal; Disease Progression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agents; Frontal Lobe; Male; Motor Activity; Neuroimmunomodulation; Rats, Long-Evans; Severity of Illness Index

2016

An 18-year-old woman with new-onset suicidal ideation while being treated with atomoxetine.

Journal of psychiatric practice, 2008, Volume: 14, Issue:1

Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Disease Progression; Female; Humans; Propylamines; Self-Injurious Behavior; Suicide, Attempted

2008